Tuesday, December 10, 2019

Naltrexone HCL Market Key Players And Growth Analysis With Forecast | 2026

The Naltrexone HCL market is mainly driven by increasing alcohol dependency worldwide. According to the 2015 National Survey on Drug Use and Health (NSDUH), 7% of the population was reported that they were engaged in heavy alcohol use. Such high prevalence of alcohol dependency is expected to drive the market during the forecast period. However, the side effects of the drug such as nausea and others may restrict the growth of the naltrexone HCL market.

Naltrexone HCL, an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. It markedly reduces or completely blocks, reversibly, the subjective effects of intravenously administered opioids. This drug is generally administered orally to treat alcohol dependence. The growing cases of alcohol dependence with increasing consumption of alcohol worldwide create a need for Naltrexone HCL.


The report segments the market on the basis of type, application, and geography. Based on type the market is segmented into medical grade and others. By application the market is categorized into opioid independence, alcohol independence, and other. A geographic breakdown and deep analysis of each of the aforesaid segments have been covered for North America, Europe, Asia-Pacific, and LAMEA.

The Major Key Players Are:

Teva Pharmaceutical Industries Ltd., Ascent Scientific Ltd., Adooq Bioscience LLC, Mallinckrodt Pharmaceuticals, and Sun Pharmaceutical Industries Limited, and others have been provided in this report.


Key Benefits
  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global naltrexone HCL market.
  • In-depth analysis has been done in this report by constructing market estimations for key market segments between 2017 and 2023.
  • This study that evaluates the competitive landscape and value chain has been taken into account to understand the competitive environment across geographies.
  • This report entails a detailed quantitative analysis of the current trends and future estimations for 2017 to 2023, which help identify prevailing market opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global naltrexone HCL market has been provided.
  • Exhaustive analysis of the global naltrexone HCL market by type helps understand the use of the drug to treat alcohol dependency.
  • An in-depth analysis of current research and clinical developments is provided with key market dynamic factors that help understand the behavior of the market.
  • Key market players have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the market
About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
https://teletype.in/@mangeshpanhale
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

No comments:

Post a Comment